🇺🇸 FDA
Patent

US 7329669

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

granted A61PA61P1/04A61P13/08

Quick answer

US patent 7329669 (Gonadotropin-releasing hormone receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P1/04, A61P13/08, A61P15/00, A61P15/08